{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:25:37Z","timestamp":1760300737890,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR07753901"],"award-info":[{"award-number":["AR07753901"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["DE022327","DE025827"],"award-info":[{"award-number":["DE022327","DE025827"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00198-022-06496-7","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T18:13:32Z","timestamp":1658600012000},"page":"2423-2433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anabolic actions of parathyroid hormone in a hypophosphatasia mouse model"],"prefix":"10.1007","volume":"33","author":[{"given":"Amy J","family":"Koh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa Kyung","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan N","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-9123","authenticated-orcid":false,"given":"Laurie K","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan E","family":"Hatch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"6496_CR1","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/0002-9343(57)90124-9","volume":"22","author":"D Fraser","year":"1957","unstructured":"Fraser D (1957) Hypophosphatasia. Am J Med 22:730\u2013746","journal-title":"Am J Med"},{"key":"6496_CR2","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1073\/pnas.142063399","volume":"99","author":"L Hessle","year":"2002","unstructured":"Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL (2002) Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A 99:9445\u20139449","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6496_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-2-40","volume":"2","author":"E Mornet","year":"2007","unstructured":"Mornet E (2007) Hypophosphatasia. Orphanet J Rare Dis 2:40","journal-title":"Orphanet J Rare Dis"},{"key":"6496_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"Whyte MP (2016) Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12:233\u2013246","journal-title":"Nat Rev Endocrinol"},{"key":"6496_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bone.2014.11.017","volume":"72","author":"KC Gasque","year":"2015","unstructured":"Gasque KC, Foster BL, Kuss P, Yadav MC, Liu J, Kiffer-Moreira T, van Elsas A, Hatch N, Somerman MJ, Millan JL (2015) Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-\/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase. Bone 72:137\u2013147","journal-title":"Bone"},{"key":"6496_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1210\/jc.2015-3462","volume":"101","author":"MP Whyte","year":"2016","unstructured":"Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson DD, Bishop N, Hofmann C (2016) Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J Clin Endocrinol Metab 101:334\u2013342","journal-title":"J Clin Endocrinol Metab"},{"key":"6496_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2213-8587(18)30307-3","volume":"7","author":"MP Whyte","year":"2019","unstructured":"Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, Taylor J, Phillips D, McGinn M, McAlister WH (2019) Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol 7:93\u2013105","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6496_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte MP, Greenberg CR, Salman NJ et al (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366:904\u2013913","journal-title":"N Engl J Med"},{"key":"6496_CR9","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00198-017-4087-z","volume":"28","author":"T Schmidt","year":"2017","unstructured":"Schmidt T, Mussawy H, Rolvien T, Hawellek T, Hubert J, Ruther W, Amling M, Barvencik F (2017) Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int 28:2653\u20132662","journal-title":"Osteoporos Int"},{"key":"6496_CR10","doi-asserted-by":"publisher","first-page":"5S71","DOI":"10.1016\/S0929-693X(18)30018-6","volume":"24","author":"KC BriotRoux","year":"2017","unstructured":"BriotRoux KC (2017) Adult hypophosphatasia. Arch Pediatr 24:5S71-75S73","journal-title":"Arch Pediatr"},{"key":"6496_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/jbmr.3928","volume":"35","author":"N Alonso","year":"2020","unstructured":"Alonso N, Larraz-Prieto B, Berg K, Lambert Z, Redmond P, Harris SE, Deary IJ, Pugh C, Prendergast J, Ralston SH (2020) Loss-of-function mutations in the alpl gene presenting with adult onset osteoporosis and low serum concentrations of total alkaline phosphatase. J Bone Miner Res 35:657\u2013661","journal-title":"J Bone Miner Res"},{"key":"6496_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10223","volume":"3","author":"K Rassie","year":"2019","unstructured":"Rassie K, Dray M, Michigami T, Cundy T (2019) Bisphosphonate use and fractures in adults with hypophosphatasia. JBMR Plus 3:e10223","journal-title":"JBMR Plus"},{"key":"6496_CR13","doi-asserted-by":"crossref","unstructured":"Warren AM EP, Grill V, Seeman E, Sztal-Mazer S (2021) Bilateral atypical femoral fractures during denosumab therapy in a patient with adult-onset hypophosphatasia. Endocrinol Diabetes Metab Case Rep 2021","DOI":"10.1530\/EDM-21-0096"},{"key":"6496_CR14","doi-asserted-by":"publisher","first-page":"e10215","DOI":"10.1002\/jbm4.10215","volume":"3","author":"T Schmidt","year":"2019","unstructured":"Schmidt T, Rolvien T, Linke C, Jandl NM, Oheim R, Amling M, Barvencik F (2019) Outcome of teriparatide treatment on fracture healing complications and symptomatic bone marrow edema in four adult patients with hypophosphatasia. JBMR Plus 3:e10215","journal-title":"JBMR Plus"},{"key":"6496_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/jbm4.10052","volume":"2","author":"P Klidaras","year":"2018","unstructured":"Klidaras P, Severt J, Aggers D, Payne J, Miller PD, Ing SW (2018) Fracture healing in two adult patients with hypophosphatasia after asfotase alfa therapy. JBMR Plus 2:304\u2013307","journal-title":"JBMR Plus"},{"key":"6496_CR16","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.4158\/ACCR-2019-0143","volume":"5","author":"AL Magdaleno","year":"2019","unstructured":"Magdaleno AL, Singh S, Venkataraman S, Perilli GA, Lee YY (2019) Adult-onset hypophosphatasia: before and after treatment with asfotase alfa. AACE Clin Case Rep 5:e344\u2013e348","journal-title":"AACE Clin Case Rep"},{"key":"6496_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.4158\/EP15890.OR","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho PM, Mazhari AM, Wilczynski C, Kadanoff R, Mumm S, Whyte MP (2016) Adult hypophosphatasia treated with teriparatide: report of 2 patients and review of the literature. Endocr Pract 22:941\u2013950","journal-title":"Endocr Pract"},{"key":"6496_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","volume":"121","author":"PS Kishnani","year":"2019","unstructured":"Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP (2019) Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone 121:149\u2013162","journal-title":"Bone"},{"key":"6496_CR19","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/jbmr.3226","volume":"32","author":"JR Shapiro","year":"2017","unstructured":"Shapiro JR, Lewiecki EM (2017) Hypophosphatasia in adults: clinical assessment and treatment considerations. J Bone Miner Res 32:1977\u20131980","journal-title":"J Bone Miner Res"},{"key":"6496_CR20","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1210\/jc.2002-021736","volume":"88","author":"KK Winer","year":"2003","unstructured":"Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr (2003) Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1\u201334) versus calcitriol and calcium. J Clin Endocrinol Metab 88:4214\u20134220","journal-title":"J Clin Endocrinol Metab"},{"issue":"391\u2013399","key":"6496_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.08.010","volume":"203","author":"KK Winer","year":"2018","unstructured":"Winer KK, Kelly A, Johns A, Zhang B, Dowdy K, Kim L, Reynolds JC, Albert PS, Cutler GB Jr (2018) Long-term parathyroid hormone 1\u201334 replacement therapy in children with hypoparathyroidism. J Pediatr 203(391\u2013399):e391","journal-title":"J Pediatr"},{"key":"6496_CR22","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1359\/jbmr.1999.14.12.2015","volume":"14","author":"KN Fedde","year":"1999","unstructured":"Fedde KN, Blair L, Silverstein J et al (1999) Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14:2015\u20132026","journal-title":"J Bone Miner Res"},{"key":"6496_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bone.2014.06.040","volume":"67","author":"J Liu","year":"2014","unstructured":"Liu J, Nam HK, Campbell C, Gasque KC, Millan JL, Hatch NE (2014) Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-\/-) mouse model of infantile hypophosphatasia. Bone 67:81\u201394","journal-title":"Bone"},{"key":"6496_CR24","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/jbmr.4389","volume":"36","author":"LE Zweifler","year":"2021","unstructured":"Zweifler LE, Koh AJ, Daignault-Newton S, McCauley LK (2021) Anabolic actions of PTH in murine models: two decades of insights. J Bone Miner Res 36:1979\u20131998","journal-title":"J Bone Miner Res"},{"key":"6496_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1","volume":"208","author":"S Narisawa","year":"1997","unstructured":"Narisawa S, Frohlander N, Millan JL (1997) Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208:432\u2013446","journal-title":"Dev Dyn"},{"key":"6496_CR26","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1210\/en.2002-220221","volume":"143","author":"B Demiralp","year":"2002","unstructured":"Demiralp B, Chen HL, Koh AJ, Keller ET, McCauley LK (2002) Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos. Endocrinology 143:4038\u20134047","journal-title":"Endocrinology"},{"key":"6496_CR27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1359\/jbmr.071211","volume":"23","author":"J Yamashita","year":"2008","unstructured":"Yamashita J, Datta NS, Chun YH, Yang DY, Carey AA, Kreider JM, Goldstein SA, McCauley LK (2008) Role of Bcl2 in osteoclastogenesis and PTH anabolic actions in bone. J Bone Miner Res 23:621\u2013632","journal-title":"J Bone Miner Res"},{"key":"6496_CR28","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0002-9440(10)62481-9","volume":"166","author":"HC Anderson","year":"2005","unstructured":"Anderson HC, Harmey D, Camacho NP, Garimella R, Sipe JB, Tague S, Bi X, Johnson K, Terkeltaub R, Millan JL (2005) Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase\/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. Am J Pathol 166:1711\u20131720","journal-title":"Am J Pathol"},{"key":"6496_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/dvdy.24370","volume":"245","author":"J Durussel","year":"2016","unstructured":"Durussel J, Liu J, Campbell C, Nam HK, Hatch NE (2016) Bone mineralization-dependent craniosynostosis and craniofacial shape abnormalities in the mouse model of infantile hypophosphatasia. Dev Dyn 245:175\u2013182","journal-title":"Dev Dyn"},{"key":"6496_CR30","doi-asserted-by":"crossref","unstructured":"Mornet E, Hofmann C, Bloch-Zupan A, Girschick H, Le Merrer M (2014) Clinical utility gene card for: hypophosphatasia - update 2013. Eur J Hum Genet 22:","DOI":"10.1038\/ejhg.2013.177"},{"key":"6496_CR31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00223-020-00771-7","volume":"108","author":"NM Jandl","year":"2021","unstructured":"Jandl NM, Schmidt T, Rolvien T et al (2021) Genotype-phenotype associations in 72 adults with suspected ALPL-associated hypophosphatasia. Calcif Tissue Int 108:288\u2013301","journal-title":"Calcif Tissue Int"},{"key":"6496_CR32","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1359\/jbmr.2000.15.10.1879","volume":"15","author":"C Wennberg","year":"2000","unstructured":"Wennberg C, Hessle L, Lundberg P, Mauro S, Narisawa S, Lerner UH, Millan JL (2000) Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res 15:1879\u20131888","journal-title":"J Bone Miner Res"},{"key":"6496_CR33","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s00198-021-06025-y","volume":"32","author":"L Seefried","year":"2021","unstructured":"Seefried L, Rak D, Petryk A, Genest F (2021) Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa. Osteoporos Int 32:2505\u20132513","journal-title":"Osteoporos Int"},{"key":"6496_CR34","doi-asserted-by":"publisher","first-page":"31515","DOI":"10.1038\/srep31515","volume":"6","author":"S Lotinun","year":"2016","unstructured":"Lotinun S, Krishnamra N (2016) Disruption of c-Kit signaling in Kit(W-sh\/W-sh) growing mice increases bone turnover. Sci Rep 6:31515","journal-title":"Sci Rep"},{"key":"6496_CR35","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1096\/fj.201701238R","volume":"32","author":"MN Michalski","year":"2018","unstructured":"Michalski MN, Seydel AL, Siismets EM, Zweifler LE, Koh AJ, Sinder BP, Aguirre JI, Atabai K, Roca H, McCauley LK (2018) Inflammatory bone loss associated with MFG-E8 deficiency is rescued by teriparatide. FASEB J 32:3730\u20133741","journal-title":"FASEB J"},{"key":"6496_CR36","first-page":"103","volume":"26","author":"S Fukuda","year":"1977","unstructured":"Fukuda S, Tomita S, Matsuoka O (1977) Comparative studies on bone growth in experimental animals. 1. Bone growth and ossification in mice (author\u2019s transl). Jikken Dobutsu 26:103\u2013113","journal-title":"Jikken Dobutsu"},{"key":"6496_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0022034512464779","volume":"92","author":"HL Chan","year":"2013","unstructured":"Chan HL, McCauley LK (2013) Parathyroid hormone applications in the craniofacial skeleton. J Dent Res 92:18\u201325","journal-title":"J Dent Res"},{"key":"6496_CR38","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1093\/hmg\/dds181","volume":"21","author":"Y Xie","year":"2012","unstructured":"Xie Y, Su N, Jin M et al (2012) Intermittent PTH (1\u201334) injection rescues the retarded skeletal development and postnatal lethality of mice mimicking human achondroplasia and thanatophoric dysplasia. Hum Mol Genet 21:3941\u20133955","journal-title":"Hum Mol Genet"},{"key":"6496_CR39","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1210\/jc.2010-1168","volume":"95","author":"C Schalin-Jantti","year":"2010","unstructured":"Schalin-Jantti C, Mornet E, Lamminen A, Valimaki MJ (2010) Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia. J Clin Endocrinol Metab 95:5174\u20135179","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06496-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-022-06496-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06496-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T06:11:06Z","timestamp":1665727866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-022-06496-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["6496"],"URL":"https:\/\/doi.org\/10.1007\/s00198-022-06496-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2022,7,23]]},"assertion":[{"value":"3 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}